Generic Zomig and Vfend Launched by Ajanta Pharma
Krystle Vermes
Ajanta Pharma Limited has been given final approval from the FDA to launch zolmitriptan tablets, 2.5 mg and 5 mg, and voriconazole tablets, 50 mg and 200 mg.
Ryan Marotta, Assistant Editor
The FDA has approved Titan Pharmaceuticals’ subcutaneous buprenorphine implant (Probuphine) for the maintenance treatment of opioid dependence.
Allison Gilchrist, Associate Editor
Several pieces of legislation heading to the White House highlight pharmacists as critical players in preventing and identifying opioid misuse and abuse.
Meghan Ross, Senior Associate Editor
As temperatures start to rise and patients head outside more frequently, it’s a good time for pharmacists to go over skin health, especially since May is Skin Cancer Awareness Month.
Meghan Ross, Senior Associate Editor
Children who show signs of aggressive behavior may benefit from omega-3, vitamin, and mineral supplementation.
Krystle Vermes
Aurobindo Pharma Limited has received final approval from the FDA to launch fenofibrate tablets, 48 mg and 145 mg.
Jeannette Y. Wick, RPh, MBA, FASCP
Clinical trials overwhelmingly support high-intensity statin therapy as secondary prophylaxis in hospitalized acute coronary syndrome patients, as it’s superior to medium- and low-intensity options.
Meghan Ross, Senior Associate Editor
Confronted with mounting medication costs, a man allegedly resorted to shooting his ill wife.

Association News

“Experts agree: generic drugs drive savings, not costs. Generics saved the U.S. health system $254 billion in 2014, according to the most recent Generic Drug Savings in the U.S. report compiled by the IMS Institute for Healthcare Informatics on behalf of GPhA.
ASHP is partnering with the Centers for Medicare & Medicaid Services to provide an online training course for hospital and critical access hospital (CAH) surveyors on pharmaceutical compounding and USP Chapter <797> standards.
Today, the Generic Pharmaceutical Association wrote a letter to Rep. Louise Slaughter (D-NY) expressing strong opposition to the Pharmaceutical Stewardship Act, a bill that would increase the cost of prescription medicines without addressing the root causes of drug abuse.
ASHP today announced the official launch of Standardize 4 Safety, a three-year, multiphase interprofessional initiative focused on creating and promoting national standard concentrations for intravenous and oral liquid medications.
National Community Pharmacists Association CEO B. Douglas Hoey, RPh, MBA, issued the following statement today in response to enactment of Oklahoma's S.B. 1150, legislation to boost transparency in generic prescription drug pricing and reimbursement.

Pharmacy Market News

Pfizer Inc. and Anacor Pharmaceuticals, Inc. have announced that they have entered into a definitive merger agreement under which Pfizer will acquire Anacor for $99.25 per Anacor share for a total transaction value of approximately $5.2 billion,
Amgen has announced the launch of the Breakaway from Heart Disease campaign to help make heart health a priority.
The Delta Foundation of Pittsburgh is pleased to announce that Mylan CEO Heather Bresch will be the first-ever CEO to participate in the Pittsburgh Pride Equality March on Sunday, June 12.

Strategic Alliance Partner News

CVS Pharmacy has announced that the company will launch digital receipts as a new option for all members of its ExtraCare Rewards program.
CVS Pharmacy has announced the grand opening of its New Orleans Lower Ninth Ward location, becoming the first major retailer to build in the neighborhood since Hurricane Katrina.
Latest Issues